Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pharmaceutical Distribution Security Alliance Applauds IOM Call for a National Supply Chain Solution

Published: Friday, February 15, 2013
Last Updated: Friday, February 15, 2013
Bookmark and Share
The Pharmaceutical Distribution Security Alliance (PDSA) issued the following statement responding to the recent Institute of Medicine’s (IOM) report.

“The Pharmaceutical Distribution Security Alliance (PDSA) applauds the Institute of Medicine (IOM) for recognizing that new legislation is needed to protect all Americans from the threat of counterfeit drugs. PDSA is particularly pleased that the IOM recognized that the supply chain can only be as strong as its weakest link and that a national solution is a necessary safeguard. As the IOM report noted, to prevent fake drugs from ending up in patients’ hands, Congress should pass legislation that creates a national system for drug distribution security.

“A state-by-state patchwork approach leaves the entire supply chain vulnerable to bad actors able to seek out states with weaker laws and regulations, placing patients at risk. The PDSA strongly supports a uniform, national standard to trace products throughout the pharmaceutical supply chain and believes such a solution should use standardized technologies and be implemented in a scalable and cost-effective manner.

“Congress made significant strides toward implementing a single, national and uniform pharmaceutical distribution supply chain solution last year but time ran out. The IOM’s recommendations following yet another FDA warning last week that more counterfeit cancer drugs had infiltrated the U.S. supply chain should spur Congress to pick up the bipartisan effort where it left off and promptly enact a single, uniform and national pharmaceutical distribution supply chain solution. The PDSA looks forward to working with all stakeholders, including the FDA, to achieve this goal.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Long-Term Culturing of Adult Stem Cells
A new procedure developed by Harvard Stem Cell Institute researchers (HSCI) at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Plant-Based Vaccine Among Front Runners In Search For New Polio Jab
A researcher from Norwich is part of a consortium that has been awarded $1.5 million to develop safer polio vaccines, using a new technique developed at the John Innes Centre.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Better Animal Model to Improve HIV Vaccine Development
Penn study identifies a new tool to produce better HIV vaccine designs.
First Large-Scale Proteogenomic Study of Breast Cancer
The study offers understanding of potential therapeutic targets.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!